Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

European MAA submitted for liquid Aricept

June 2, 2004

Preclinical milestone reached in Neurogen/Merck & Co pain alliance

June 2, 2004

Roche researchers describe 5-HT receptor ligands for psychoses, dementia, etc.

June 1, 2004

Orphan drug status for PD-6735

June 1, 2004

New analgesic vanilloid VR1 antagonists emerge from Novartis R&D

May 28, 2004

New adenosine A2A antagonists for PD, depression, dementia, etc.

May 27, 2004

Selective calcium channel inhibitor blocks hyperalgesia effectively in vivo

May 27, 2004

Enrollment completed in ADHD phase II study of NS-2359

May 27, 2004

Fast track designation for INO-1001

May 27, 2004

New GABA-A receptor modulators in early development at Neurogen

May 26, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...